Učitavanje...
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid‐PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG‐PET), we evaluated data from N = 268 healthy c...
Spremljeno u:
| Izdano u: | Ann Clin Transl Neurol |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562030/ https://ncbi.nlm.nih.gov/pubmed/31211176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.782 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|